Retrospective Study
Copyright ©The Author(s) 2022.
World J Clin Cases. Jul 26, 2022; 10(21): 7314-7323
Published online Jul 26, 2022. doi: 10.12998/wjcc.v10.i21.7314
Table 3 Comparison of hemodynamic parameters before and after treatment between the two groups (mean ± SD)
Group
Before treatment
Treatment 24 h
Treatment 48 h
Treatment 72 h
CVP (mmHg)
Sequential group (n = 54)7.75 ± 0.548.34 ± 0.668.40 ± 0.588.38 ± 0.57
Regular group (n = 54)7.81 ± 0.488.06 ± 0.538.23 ± 0.558.21 ± 0.60
t value-0.610 2.431 1.563 1.509
P value0.543 0.017 0.121 0.134
HR (times/min)
Sequential group (n = 54)90.3 ± 6.988.8 ± 7.489.4 ± 7.888.5 ± 8.0
Regular group (n = 54)92.0 ± 7.390.5 ± 8.288.6 ± 8.289.3 ± 7.4
t value-1.244 -1.131 0.519 -0.539
P value0.216 0.261 0.605 0.591
CO (L/min)
Sequential group (n = 54)3.82 ± 0.673.94 ± 0.624.04 ± 0.584.09 ± 0.62
Regular group (n = 54)3.90 ± 0.523.87 ± 0.553.91 ± 0.524.00 ± 0.57
t value-0.693 0.621 1.226 0.785
P value0.490 0.536 0.223 0.434
CI
Sequential group (n = 54)3.04 ± 0.483.14 ± 0.513.11 ± 0.483.15 ± 0.45
Regular group (n = 54)3.11 ± 0.423.04 ± 0.483.04 ± 0.453.10 ± 0.47
t value-0.807 1.049 0.782 0.565
P value0.422 0.296 0.436 0.573
SVV (%)
Sequential group (n = 54)4.51 ± 0.384.72 ± 0.344.58 ± 0.414.59 ± 0.38
Regular group (n = 54)4.46 ± 0.404.50 ± 0.384.34 ± 0.354.42 ± 0.41
t value0.666 3.171 3.272 2.235
P value0.507 0.002 0.001 0.028